Anti-complement effects of two anti-inflammatory agents: Niflumic and flufenamic acids
- 15 November 1974
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 23 (22) , 3107-3120
- https://doi.org/10.1016/0006-2952(74)90596-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a terminal sulfonyl fluorideJournal of Medicinal Chemistry, 1971
- Neutrophil chemotactic factors and related clinical disordersArthritis & Rheumatism, 1970
- C[unk] inactivator inhibition by plasminJournal of Clinical Investigation, 1970
- Irreversible enzyme inhibitors. CLIII. Proteolytic enzymes. 11. Inhibition of guinea pig complement by substituted phenoxyacetamidesJournal of Medicinal Chemistry, 1969
- Irreversible enzyme inhibitors. CLII. Proteolytic enzymes. 10. Inhibition of guinea pig complement by substituted benzamidinesJournal of Medicinal Chemistry, 1969
- A PLASMIN-SPLIT FRAGMENT OF C'3 AS A NEW CHEMOTACTIC FACTORThe Journal of Experimental Medicine, 1967
- THE CONVERSION OF C'1S TO C'1 ESTERASE BY PLASMIN AND TRYPSINThe Journal of Experimental Medicine, 1967
- Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serumImmunochemistry, 1966
- THE REACTION MECHANISM OF ß1C-GLOBULIN (C'3) IN IMMUNE HEMOLYSISThe Journal of Experimental Medicine, 1966
- Inhibition of guinea pig C′2 by rabbit: Quantitative measurement of inhibition, discrimination between immune inhibition and complement fixation, specificity of inhibition and demostration of uptake of C′2 by EAC′1a,4Immunochemistry, 1965